source
- GSK partners with Sino Biopharma to expand access to hepatitis B drug bepirovirsen in ChinaGSK announced a marketing agreement with Sino Biopharmaceutical to distribute its experimental hepatitis B therapy bepirovirsen in China. Sino's subsidiary will purchase a supply of the drug and u…
- Daiichi Sankyo targets $15 billion in oncology sales by 2030 as it expands ADC franchiseDaiichi Sankyo released a new five‑year business plan that sets a goal of nearly $15 billion in oncology revenue by 2030. The target is part of a broader ambition to push total company sales past 3…